Archives
-
FOXM1 and ERα in Female Lung Adenocarcinoma
2026-09-24
A multi-dataset analysis and cell-based experiments identify elevated FOXM1 as a feature of female lung adenocarcinoma and propose a ceRNA network linking miR-204-5p, FOXM1, and estrogen receptor 1. The findings suggest candidate biomarkers and research questions, but the proposed network and computational immunotherapy associations require further mechanistic and clinical validation.
-
Cy5.5 NHS Ester for BBB Nanoparticle Tracking
2026-09-23
Learn how Cy5.5 NHS ester (non-sulfonated) can support fluorescence tracking of targeted nanoparticles—and why a bright signal alone cannot prove blood–brain barrier crossing or particle integrity. This assay-focused guide connects near-infrared labeling chemistry with practical decisions in epilepsy nanotherapy research.
-
FerroOrange: Reading Fe²⁺ in Ferroptosis
2026-09-23
FerroOrange is an Fe²⁺ fluorescent probe for live-cell analysis of labile ferrous iron. This article explains how to interpret its signal in ferroptosis and ischemic-injury studies without confusing Fe²⁺ dynamics with total iron or causal proof.
-
Phosbind Acrylamide for Phosphorylation Analysis
2026-09-22
Phosbind Acrylamide enables antibody-free separation of phosphorylated and non-phosphorylated proteins directly in SDS-PAGE. This practical guide applies the approach to kinase assays and jasmonate-regulated plant signaling, with optimization controls for reliable mobility-shift interpretation.
-
p-Cresyl Sulfate: From Uremic Toxin to Valve Risk
2026-09-22
p-Cresyl sulfate is emerging as more than a retention marker in chronic kidney disease. This thought-leadership article connects endothelial dysfunction, valvular calcification, klotho/SIRT1 signaling, and translational assay design to guide cardiovascular and renal researchers.
-
ARCA EGFP mRNA: From Signal to Confidence
2026-09-21
A thought-leadership guide to using ARCA EGFP mRNA as a mechanistically informed mRNA transfection control, linking direct fluorescence readouts with cell-context biology, delivery-system benchmarking, and translational assay strategy.
-
IEM 1460: AMPA Receptor Blocker Workflows
2026-09-21
IEM 1460 enables selective AMPA receptor inhibition assays that separate fast glutamatergic signaling from broader neurotoxicity effects. This workflow guide translates recent glutamate-receptor research into practical assay design, dose-finding, neuroprotection testing, and troubleshooting strategies.
-
Deferiprone as a Precision Iron-Stress Probe
2026-09-20
Deferiprone, also known as 3-hydroxy-1,2-dimethylpyridin-4-one, is more than an iron chelator: it is a tunable probe for linking iron availability to proliferation, metabolism, redox balance, and apoptosis. This article translates enterocyte metabolomics into practical assay design for cancer biology and neurovascular research.
-
SP2509: Lysine-Specific Demethylase 1 Antagonist
2026-09-19
SP2509 is a Lysine-specific demethylase 1 antagonist with a reported LSD1 enzymatic IC50 of 13 nM. Its research profile includes CoREST disruption, promoter-specific H3K4Me3 elevation, apoptosis induction in AML cells, and differentiation effects in acute myeloid leukemia models.
-
SepM Mutations and S. mutans–S. gordonii Inhibition
2026-09-18
Liu et al. linked recurrent sepM missense mutations in clinical Streptococcus mutans isolates with stronger inhibition of Streptococcus gordonii and examined how selected substitutions alter SepM–CSP-21 binding. The work combines isolate-level genetics, expression analysis, recombinant protein studies, and pH-dependent affinity measurements to connect bacterial variation with interspecies competition.
-
IAM LC vs LEKC for Pulmonary Drug Permeability
2026-09-18
The reference study provides a direct comparison of immobilised artificial membrane liquid chromatography and liposome electrokinetic capillary chromatography for modelling drug–membrane partitioning and pulmonary permeability. Its results show that LEKC can better reflect phospholipid-mediated interactions and lung permeability, whereas IAM LC offers broader compound coverage, simpler operation, and stronger suitability for automated screening.
-
Two Flavone 2′-Glucosides from Scutellaria baicalensis
2026-09-17
The 1995 reference study established two previously unreported flavone 2′-O-glucosides from Scutellaria baicalensis roots and identified seven additional phenolics, including baicalin methyl ester. Its value is primarily phytochemical: chromatographic isolation and multidimensional spectral analysis authenticated structures that can now serve as starting points for mechanistic studies, while the paper itself did not test intestinal barrier activity or anti-inflammatory effects.
-
Anagliptin (SK-0403): DPP-4 and Vascular Mechanisms
2026-09-17
Anagliptin (SK-0403) is an orally active DPP-4 inhibitor with a reported IC50 of 3.8 nM. In rabbit aortic rings, the compound produced vasorelaxation associated with Kv channel and SERCA pump activity, while classic cyclic-nucleotide pathways and the endothelium were not required.
-
Diuron: From Photosynthesis to Renal Toxicology
2026-09-16
Diuron is both a mechanistically defined photosynthesis inhibitor and a valuable model for environmental toxicology. This article presents an assay-translation framework linking its plant target to emerging evidence on JAK2/STAT1-associated renal injury.
-
Dehydroepiandrosterone (DHEA) Experimental Workflows
2026-09-16
Build reproducible DHEA workflows for PCOS models, granulosa-cell apoptosis, macrophage-conditioned media, and neuroprotection studies. This guide connects dose selection and vehicle control with practical assays for granulosa cell proliferation, hippocampal neuron protection, and apoptosis inhibition.